Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Foresite Capital Management V, LLC
Form 13F · Q2 2026

Foresite Capital Management V, LLC

CIK 1792206Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$362M
Reported book value
9
Positions
12
Quarters on record
Top 50
Positions

Foresite Capital Management V, LLC — holdings

Top 9 positions of 9, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ALMS Alumis Inc5.9M+0.0%$166M45.8%
2CGON Cg Oncology Inc1.1M+7.5%$77M21.2%
3IRON Disc Medicine Inc374,069+0.0%$27M7.6%
4HIMS Hims & Hers Health Inc738,151+0.0%$26M7.1%
5PHVS Pharvaris N V664,142+242.1%$23M6.3%
6EIKN Eikon Therapeutics Inc1.3M+0.0%$17M4.8%
7ODTX Odyssey Therapeutics Inc713,105—$13M3.7%
8LYEL Lyell Immunopharma Inc476,386−0.1%$7M1.8%
9NRIX Nurix Therapeutics Inc265,000+0.0%$6M1.8%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.